Related Experiment Video
Updated: Aug 11, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
RNA-binding proteins in vascular inflammation and atherosclerosis
Marco Sachse1, Simon Tual-Chalot2, Giorgia Ciliberti3
1Department of Cardiovascular Research, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Department of Cardiovascular Surgery, University Heart Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Insights
RNA-binding proteins (RBPs) regulate gene expression post-transcriptionally, impacting vascular cells in atherosclerotic cardiovascular disease (ASCVD). Understanding cell-specific RBP functions offers new avenues for precision medicine therapeutics in ASCVD.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Genetics
Background:
- Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of global mortality, persisting despite optimal clinical treatments.
- Gene expression is regulated at multiple levels, including post-transcriptional control, which influences cellular function.
- RNA-binding proteins (RBPs) are critical regulators of RNA metabolism and gene expression.
Purpose of the Study:
- To review the cell-specific roles of RBPs in vascular inflammation and atherosclerosis.
- To highlight how RBP functions in ASCVD can inform the development of novel therapeutics.
- To provide an overview of RBP involvement across all stages of ASCVD.
Main Methods:
- Literature review focusing on cell-specific RBP functions in ASCVD.
- Analysis of emerging evidence on RBPs in vascular endothelial cells, smooth muscle cells, and immune cells.
- Synthesis of current knowledge on post-transcriptional regulation in atherosclerosis.
Main Results:
- RBPs act as key co- and post-transcriptional regulators in vascular cells relevant to ASCVD.
- Specific RBPs influence vascular inflammation and the development of atherosclerosis.
- Cell-specific RBP functions are implicated in various stages of ASCVD pathogenesis.
Conclusions:
- RBPs play a crucial role in the cellular mechanisms underlying ASCVD.
- Targeting cell-specific RBPs presents a promising strategy for precision medicine in ASCVD.
- Further research into RBP functions can lead to innovative therapeutic approaches for atherosclerotic disease.
Abstract:
Atherosclerotic cardiovascular disease (ASCVD) remains the major cause of premature death and disability worldwide, even when patients with an established manifestation of atherosclerotic heart disease are optimally treated according to the clinical guidelines. Apart from the epigenetic control of transcription of the genetic information to messenger RNAs (mRNAs), gene expression is tightly controlled at the post-transcriptional level before the initiation of translation. Although mRNAs are traditionally perceived as the messenger molecules that bring genetic information from the nuclear DNA to the cytoplasmic ribosomes for protein synthesis, emerging evidence suggests that processes controlling RNA metabolism, driven by RNA-binding proteins (RBPs), affect cellular function in health and disease. Over the recent years, vascular endothelial cell, smooth muscle cell and immune cell RBPs have emerged as key co- or post-transcriptional regulators of several genes related to vascular inflammation and atherosclerosis. In this review, we provide an overview of cell-specific function of RNA-binding proteins involved in all stages of ASCVD and how this knowledge may be used for the development of novel precision medicine therapeutics.
Related Concept Videos
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Regulation of Angiogenesis and Blood Supply
Atherosclerosis I: Introduction
RNA Polymerase II Accessory Proteins
RNA Editing
Inflammation

